TG Therapeutics Inc logo

TG Therapeutics Inc

NEW
STU:NKB2 (USA)   Ordinary Shares
€ 42.4 +0.50 (+1.19%) Aug 17
17.99
P/B:
12.49
Market Cap:
€ 6.52B ($ 7.55B)
Enterprise V:
€ 6.69B ($ 7.75B)
Volume:
0
Avg Vol (2M):
173.00
Trade In:

TG Therapeutics Inc Operating Data

TG Therapeutics Inc Competitors' Latest Operating Data

Operating data not available.

TG Therapeutics Inc (STU:NKB2) Operating Data Charts